Nasdaq Stockholders’ Equity |
6 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Jun. 30, 2026 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Equity [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Nasdaq Stockholders' Equity | NASDAQ STOCKHOLDERS’ EQUITY Common Stock As of June 30, 2026, 900,000,000 shares of our common stock were authorized, 587,518,685 shares were issued and 561,990,385 shares were outstanding. As of December 31, 2025, 900,000,000 shares of our common stock were authorized, 594,620,320 shares were issued and 569,894,024 shares were outstanding. The holders of common stock are entitled to one vote per share, except that our certificate of incorporation limits the ability of any shareholder to vote in excess of 5.0% of the then-outstanding shares of Nasdaq common stock. Common Stock in Treasury, at Cost We account for the purchase of treasury stock under the cost method with the shares of stock repurchased reflected as a reduction to Nasdaq stockholders’ equity and included in common stock in treasury, at cost in the Condensed Consolidated Balance Sheets. Shares repurchased under our share repurchase program are currently retired and canceled and are therefore not included in the common stock in treasury balance. If treasury shares are reissued, they are recorded at the average cost of the treasury shares acquired. We held 25,528,300 shares of common stock in treasury as of June 30, 2026 and 24,726,296 shares as of December 31, 2025, most of which are related to shares of our common stock withheld for the settlement of employee tax withholding obligations arising from the vesting of restricted stock and PSUs. Share Repurchase Program In February 2026, our board of directors authorized an increase to our share repurchase program, bringing the aggregate authorized amount to $3.0 billion. As of June 30, 2026, the remaining aggregate authorized amount under the existing share repurchase program was $2.5 billion. As part of this program, repurchases may be made from time to time at prevailing market prices in open market purchases, privately-negotiated transactions, block purchase techniques, an accelerated share repurchase program or otherwise, as determined by our management. The repurchases are primarily funded from existing cash balances. The share repurchase program may be suspended, modified or discontinued at any time, and has no defined expiration date. The following is a summary of our share repurchase activity, reported based on settlement date, for the six months ended June 30, 2026:
The table above excludes an aggregate of 802,004 shares withheld to satisfy tax obligations of the grantee upon the vesting of restricted stock and PSUs. In January 2026, we entered into a $300 million variable notional ASR agreement and, upon final settlement in February 2026, we received a total of 3,142,730 shares plus $15 million cash reflecting the difference between the prepayment and final notional amount. These shares are included in the number of shares of common stock repurchased in the table above. In July 2026, we entered into a variable notional ASR agreement, for which we paid $250 million to a third-party financial institution in exchange for an initial delivery of shares of common stock. The final notional amount is subject to a minimum and maximum and will depend on the price of our shares of common stock during the term of the ASR. The final settlement of the ASR agreement is expected to be completed in the third quarter of 2026. Under ASR agreements, we make payments to our counterparties and receive an initial delivery of shares of common stock. The final number of shares to be repurchased is based on the volume-weighted average price of Nasdaq's common stock during the term of the ASR agreement, less a discount and subject to adjustments pursuant to the terms of the ASR agreement. At settlement, our counterparty may be required to deliver additional shares of common stock to us or, under certain circumstances, we may be required to deliver shares of our common stock or may elect to make a cash payment to our counterparty. Receiving our shares of common stock, during initial delivery and the final receipt of shares upon settlement of the ASR agreements, results in an immediate reduction of the outstanding shares used to calculate the weighted-average common shares outstanding for basic and diluted earnings per share. Preferred Stock Our certificate of incorporation authorizes the issuance of 30,000,000 shares of preferred stock, par value $0.01 per share, issuable from time to time in one or more series. As of June 30, 2026 and December 31, 2025, no shares of preferred stock were issued or outstanding. Cash Dividends on Common Stock During the six months ended June 30, 2026, our board of directors declared and paid the following cash dividends:
The total amount paid of $327 million was recorded in retained earnings in the Condensed Consolidated Balance Sheets at June 30, 2026. In July 2026, the board of directors approved a regular quarterly cash dividend of $0.31 per share on our outstanding common stock. The dividend is payable on September 25, 2026 to shareholders of record at the close of business on September 11, 2026. The estimated aggregate payment of this dividend is $174 million. Future declarations of quarterly dividends and the establishment of future record and payment dates are subject to approval by the board of directors. The board of directors maintains a dividend policy with the intention to provide shareholders with regular and increasing dividends as earnings and cash flows increase.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||